Table 3.
Patients’ characteristics by group of pathologies.
| Total | Malignancy | Infection | Other inflammatory |
Other non- inflammatory |
No diagnosis | |
|---|---|---|---|---|---|---|
| N | 420 (100) | 119 (28.3) | 44 (10.5) | 71 (16.9) | 116 (27.6) | 70 (16.7) |
| Sex (F/M) (N) | 213/207 | 48/71 | 13/31 | 40/31 | 69/47 | 43/27 |
| Age (median) | 53 (39–67) | 64 (51.5–73) | 43 (28.5–53) | 49 (33.5–66) | 53 (39–64) | 47 (39.5–61) |
| BMI (median) | 24 (21–27.4) | 24.3 (21.4–27.1) | 22.9 (19.2–25) | 23.6 (21.3–28) | 25 (22.5–30.8) | 23.6 (20.5–27.3) |
| Menopausea (N) | 111 (52.4) | 36 (75) | 3 (23.1) | 17 (42.5) | 41 (59.4) | 14 (33.3) |
| Medical history (N) | ||||||
| IDb | 76 (18.1) | 17 (14.3) | 8 (18.2) | 17 (23.9) | 20 (17.2) | 14 (20) |
| HIV | 17 (4) | 5 (4.2) | 4 (9.1) | 1 (1.4) | 4 (3.4) | 3 (4.3) |
| SOTc | 15 (3.6) | 4 (3.4) | 2 (4.5) | 1 (1.4) | 4 (3.4) | 4 (5.7) |
| Sleep apnoea | 23 (5.5) | 4 (3.4) | 1 (2.3) | 1 (1.4) | 11 (9.5) | 6 (8.6) |
| Smokers | 119 (28.3) | 28 (23.5) | 13 (29.5) | 17 (23.9) | 36 (31) | 25 (35.7) |
| Hospitalized | 226 (53.8) | 80 (67.2) | 31 (70.5) | 45 (63.4) | 46 (39.7) | 24 (34.3) |
| Duration (N) | ||||||
| 15 to 21 days | 19 (4.5) | 2 (1.7) | 10 (22.7) | 3 (4.2) | 3 (2.6) | 1 (1.4) |
| ≥ 21 days to 3 months | 192 (45.7) | 69 (58) | 21 (47.7) | 30 (42.3) | 47 (40.5) | 25 (35.7) |
| ≥ 3 months to 12 months | 124 (29.5) | 39 (32.8) | 12 (27.3) | 21 (29.6) | 32 (27.6) | 20 (28.6) |
| ≥ 1 year | 85 (20.2) | 9 (7.6) | 1 (2.3) | 17 (23.9) | 34 (29.3) | 24 (34.3) |
| Fever (N) | 87 (20.9) | 26 (24.8) | 22 (51.2) | 28 (39.4) | 7 (6) | 4 (5.7) |
| General state impairment (N) | 248 (59) | 98 (82.4) | 33 (75) | 51 (71.8) | 39 (33.6) | 27 (38.6) |
| Symptoms’ occurrence (N) | ||||||
| Night only | 375 (89.3) | 106 (89.1) | 40 (90.1) | 70 (98.6) | 97 (83.6) | 62 (88.6) |
| Night and day | 42 (10) | 12 (10.1) | 4 (9.1) | 19 (26.8) | 1 (0.9) | 6 (8.6) |
| Day only | 3 (0.7) | 1 (0.8) | 0 | 0 | 0 | 2 (2.9) |
| Laboratory characteristics | ||||||
| CRP (mg/l) | 8.2 (1.3–55.6) | 26 (4.9–85.2) | 44.1 (6.1–86.3) | 14.9 (1.3–72.4) | 2.2 (0.7–8.2) | 1.2 (0.7–2.2) |
| LDH (UI/l) | 235 (187–313) | 261 (206–354) | 235 (170–247) | 235 (191–266) | 223 (180–260) | 183 (159–240) |
| WBCd (109 cells/l) | 8 (6–10.8) | 9.1 (7–13.6) | 7.9 (5.8–10.5) | 8.2 (5.9–11.1) | 7.4 (6–8.8) | 6.6 (4.8–8.4) |
| Lymphocytes (109 cells/l) | 1.7 (1.2–2.3) | 1.5 (0.9–2.2) | 1.6 (1.1–2.2) | 1.8 (1.2–2.3) | 2 (1.5–2.4) | 1.9 (1.4–2.6) |
| Neutrophils (109 cells/l) | 5 (3.3–7.2) | 5.7 (3.7–8.2) | 5.3 (3.3–7.1) | 5.2 (3.1–8) | 4.5 (3.3–6) | 3.9 (2.8–5.2) |
| Haemoglobin (g/dl) | 12.9 (11.4–13.9) | 11.8 (10.7–13.2) | 12.8 (11.8–13.5) | 12.4 (11.3–13.9) | 13.6 (12.6–14.4) | 13.7 (12.3–15.1) |
Data are N (%) or median (± IQR).
aAmong the female population. bImmunodeficiency. cSolid organ transplant. dWhite blood cells.